Dare Bioscience, Inc. (DARE): Valuation
TTM figures as of June 30, 2026
Dare Bioscience, Inc. trades at a -84.65% free-cash-flow yield. That FCF yield is higher than 14% of its own month-end history back to 2014.
Earnings yield -79.12%. Net cash $12.5M.
149 month-end valuation observations are on file, starting April 2014.
Sector comparison uses 2682 Healthcare names.
Frequently asked questions
Is DARE cheap versus its own history?
Dare Bioscience, Inc. trades at a -84.65% free-cash-flow yield. That FCF yield is higher than 14% of its own month-end history back to 2014.
What is DARE's free-cash-flow yield?
Dare Bioscience, Inc. currently yields -84.65% of market cap as trailing free cash flow.
Where do these valuation figures come from?
Yields and quality metrics are computed from the same SEC TTM figures as the financials page, against the live market cap. Historical bands reconstruct month-end market cap from split-adjusted closes and the share count in the units it was filed, then divide by those dollar totals. Nothing here is a third-party estimate.